Replies to post #49610 on Biotech Values

[kcalt]

Re: NVD - As far as Zensana goes, HNAB is stability testing NVD's European formulation. HNAB disclosed in a PR that they believe they have discovered the "root cause of the precipitate after lengthy investigation." As of now, the Euro formulation has surpassed the stability point where the original formulation failed. They are going to sell the licensing rights to a partner who will take the development of Zensana forward to the clinic for another go.